Uncategorised - European Medical Journal

New Insights into Functional Anorectal Pain Mechanisms

Patients with functional anorectal pain show abnormal anal pressures, rectal hypersensitivity, and high rates of anxiety and depression, new study reveals.

Interchanging Pain Scores Not Advised in Spondyloarthritis

New simulation data suggest that fatigue scores can sometimes be substituted in spondyloarthritis registries, but pain and global scores should remain distinct.

Mycoplasma Pneumoniae Epidemic Strains ICUs Amid Atypical Presentations

High ICU admission rates and atypical features marked France’s recent M. pneumoniae epidemic, especially in those without early macrolide therapy.

Self-Injection Device Offers Safe At-Home Acne Relief

Researchers developed a self-injection assistance device, allowing patients to administer triamcinolone themselves under medical guidance.

Beyond the Lungs: Addressing Cardiopulmonary Risk in COPD

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania and Cambier…

Clinical and Economic Impact of Bronchiectasis

Bronchiectasis is a chronic and progressive inflammatory lung disease, characterized by permanent and abnormal dilatation of the bronchi…

New Clues to Early Melanoma Development

A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps in skin cancer progression

Updated EAU Guidelines Transform Bladder Cancer Management

The guidelines endorse adjuvant nivolumab for patients with pT3/4 and/or pN+ disease who are unsuitable for, or have declined, cisplatin-based chemotherapy.

Breast MRI Often Underestimates Tumor Size After Therapy

Post-treatment MRI frequently underestimates tumor size in patients with invasive lobular carcinoma (ILC) who receive neoadjuvant therapy, according to new findings that may influence surgical planning in this breast cancer subtype.

Dupilumab Linked to Higher Lymphoma Risk in Patients with Asthma

Dupilumab was associated with increased lymphoma risk but lower overall mortality in a large asthma cohort study.